4.1 Article

Psychotropic Drugs on In Vitro Brain-Derived Neurotrophic Factor Production in Whole Blood Cell Cultures From Healthy Subjects

Journal

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Volume 30, Issue 5, Pages 623-627

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JCP.0b013e3181f13f0b

Keywords

antidepressant; antipsychotics; BDNF; whole blood

Funding

  1. Ministry of Health and Welfare, Republic of Korea [A040042]

Ask authors/readers for more resources

The aim of this study was to evaluate the effects of certain antidepressant and antipsychotic drugs on the in vitro production of brain-derived neurotrophic factor (BDNF) in whole blood cell culture from healthy volunteers. Whole blood cells from 41 healthy volunteers were stimulated with or without phytohemagglutinin and lipopolysaccharides with treatments of amitriptyline, paroxetine, mirtazapine, and venlafaxine, which are antidepressant drugs, and haloperidol and clozapine, which are antipsychotic drugs. Brain-derived neurotrophic factor levels were measured in supernatants of unstimulated and stimulated whole blood cell cultures. When the effects of each antidepressant agent at the therapeutic concentration were compared with the effects in control subjects using the Wilcoxon test, the in vitro BDNF production was significantly enhanced in the stimulated cultures treated with amitriptyline (P = 0.021). When analyzing the change in the BDNF productions by each of the drugs using the Friedman test, amitriptyline significantly increased the BDNF production in stimulated cultures (P = 0.002), whereas paroxetine, mirtazapine, and venlafaxine did not stimulate the BDNF production (P > 0.05). However, BDNF production by amitriptyline was only increased by 12% to 17%. Haloperidol and clozapine at therapeutic concentrations did not significantly alter the BDNF production in unstimulated and stimulated whole blood cells (P > 0.05). Our study suggests that some antidepressant and antipsychotic agents do not have a direct effect on increasing the BDNF production in whole blood cells during immediate treatment. Thus, the level of BDNF production in human blood cells may not influence the plasma or serum BDNF levels of subjects in clinical studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Clinical Neurology

A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder

Yong-Ku Kim, Meysam Amidfar, Eunsoo Won

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Review Clinical Neurology

Differentiating between bipolar and unipolar depression in functional and structural MRI studies

Kyu-Man Han, Domenico De Berardis, Michele Fornaro, Yong-Ku Kim

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Review Clinical Neurology

Interactive effects of genetic polymorphisms and childhood adversity on brain morphologic changes in depression

Yong-Ku Kim, Byung-Joo Ham, Kyu-Man Han

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Editorial Material Clinical Neurology

Promising neural diagnostic biomarkers and predictors of treatment outcomes for psychiatric disorders: Novel neuroimaging approaches

Kyu-Man Han, Yong-Ku Kim

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Review Psychiatry

A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder

Seon-Cheol Park, Yong-Ku Kim

PSYCHIATRY INVESTIGATION (2019)

Review Pharmacology & Pharmacy

Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System

Carmine Tomasetti, Chiara Montemitro, Annastasia L. C. Fiengo, Cristina Santone, Laura Orsolini, Alessandro Valchera, Alessandro Carano, Maurizio Pompili, Gianluca Serafini, Giampaolo Perna, Federica Vellante, Giovanni Martinotti, Massimo D. Giannantonio, Yong-Ku Kim, Marco D. Nicola, Antonello Bellomo, Antonio Ventriglio, Michele Fornaro, Domenico D. Berardis

CURRENT PHARMACEUTICAL DESIGN (2019)

Article Clinical Neurology

Intimate partner violence and incidence of depression in married women: A longitudinal study of a nationally representative sample

Kyu-Man Han, Hee-Jung Jee, Hyonggin An, Cheolmin Shin, Ho-Kyoung Yoon, Young-Hoon Ko, Byung-Joo Ham, Yong-Ku Kim, Changsu Han

JOURNAL OF AFFECTIVE DISORDERS (2019)

Review Clinical Neurology

The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research

Meysam Amidfar, Marie Woelfer, Gislaine Z. Reus, Joao Quevedo, Martin Walter, Yong-Ku Kim

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Editorial Material Neurosciences

Neuron-to-microglia Crosstalk in Psychiatric Disorders

Youn Jung Lee, Yong-Ku Kim

CURRENT NEUROPHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches

Cheolmin Shin, Yong-Ku Kim

CURRENT OPINION IN PHARMACOLOGY (2019)

Article Clinical Neurology

Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders

Cheolmin Shin, Moon Ho Park, Seung-Hoon Lee, Young-Hoon Ko, Yong-Ku Kim, Kyu-Man Han, Hyun-Ghang Jeong, Changsu Han

JOURNAL OF AFFECTIVE DISORDERS (2019)

Review Biochemistry & Molecular Biology

Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders

Eunsoo Won, Yong-Ku Kim

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Crosstalk between Depression and Dementia with Resting-State fMRI Studies and Its Relationship with Cognitive Functioning

Junhyung Kim, Yong-Ku Kim

Summary: Alzheimer's disease is the most common type of dementia, with depression being a risk factor for its development. While depression patients often recover without residual symptoms, late-life depression patients may show residual cognitive impairment. Understanding how risk factors impact the course of Alzheimer's disease is crucial for its management.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment

Lorenza Lucidi, Mauro Pettorruso, Federica Vellante, Francesco Di Carlo, Franca Ceci, Maria Chiara Santovito, Ilenia Di Muzio, Michele Fornaro, Antonio Ventriglio, Carmine Tomasetti, Alessandro Valchera, Alessandro Gentile, Yong-Ku Kim, Giovanni Martinotti, Silvia Fraticelli, Massimo Di Giannantonio, Domenico De Berardis

Summary: The gut microbiota plays a crucial role in maintaining homeostasis, growth, and digestive processes. It also influences the intercommunication system between the gut and the brain, potentially impacting the pathogenesis and clinical management of Bipolar Disorder. Current literature suggests a relationship between compositional alterations in the gut microbiota and BD, with potential benefits in treating BD symptoms through modifications in the microbiota composition. Further research is needed to explore the potential of correcting gut microbiota alterations as a novel strategy in BD management.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression

Eunsoo Won, Kyoung-Sae Na, Yong-Ku Kim

Summary: Inflammatory conditions and disruptions in circadian rhythms, including alterations in the melatonin system, have been suggested as mechanisms underlying major depressive disorder. Melatonin, with its immunological and non-immunological actions, can suppress inflammation and influence neuroinflammation and neurotoxicity, leading to alterations in brain regions implicated in depression. Further research on the associations between melatonin, immune markers, and brain structure and function may help identify potential biomarkers for MDD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

No Data Available